Neurodegenerative Diseases: From Molecular Basis to Therapy.

Luisa Agnello, Marcello Ciaccio
Author Information
  1. Luisa Agnello: Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, University of Palermo, 90127 Palermo, Italy.
  2. Marcello Ciaccio: Department of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Clinical Laboratory Medicine, University of Palermo, 90127 Palermo, Italy. ORCID

Abstract

Neurodegenerative diseases (NDs) are a heterogeneous group of complex diseases characterized by neuronal loss and progressive degeneration of different areas of the nervous system [...].

References

  1. Int J Mol Sci. 2021 Aug 11;22(16): [PMID: 34445359]
  2. Int J Mol Sci. 2022 Feb 06;23(3): [PMID: 35163768]
  3. Int J Mol Sci. 2021 Oct 20;22(21): [PMID: 34768760]
  4. Int J Mol Sci. 2021 Nov 02;22(21): [PMID: 34769314]
  5. Int J Mol Sci. 2022 Jul 29;23(15): [PMID: 35955549]
  6. Int J Mol Sci. 2021 Nov 08;22(21): [PMID: 34769517]
  7. Lab Med. 2021 Mar 15;52(2):188-196 [PMID: 32926148]
  8. Int J Mol Sci. 2022 May 13;23(10): [PMID: 35628278]
  9. Int J Mol Sci. 2022 Mar 08;23(6): [PMID: 35328335]
  10. Int J Mol Sci. 2022 Feb 12;23(4): [PMID: 35216146]
  11. Int J Mol Sci. 2021 Sep 11;22(18): [PMID: 34576000]
  12. Int J Mol Sci. 2021 Dec 22;23(1): [PMID: 35008538]

MeSH Term

Humans
Neurodegenerative Diseases

Word Cloud

Created with Highcharts 10.0.0NeurodegenerativediseasesNDsheterogeneousgroupcomplexcharacterizedneuronallossprogressivedegenerationdifferentareasnervoussystem[]Diseases:MolecularBasisTherapy

Similar Articles

Cited By (28)